Abeona Historical Income Statement
ABEO Stock | USD 7.25 0.09 1.23% |
Historical analysis of Abeona Therapeutics income statement accounts such as Interest Expense of 397.1 K, Selling General Administrative of 18.1 M or Total Revenue of 3.3 M can show how well Abeona Therapeutics performed in making a profits. Evaluating Abeona Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Abeona Therapeutics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Abeona Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Abeona Therapeutics is a good buy for the upcoming year.
Abeona |
About Abeona Income Statement Analysis
Abeona Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Abeona Therapeutics shareholders. The income statement also shows Abeona investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Abeona Therapeutics Income Statement Chart
Abeona Therapeutics Income Statement is one of the three primary financial statements used for reporting Abeona's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Abeona Therapeutics revenue and expense. Abeona Therapeutics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Abeona Therapeutics' Reconciled Depreciation is very stable compared to the past year. Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Abeona Therapeutics. It is also known as Abeona Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Abeona Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Abeona Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abeona Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.At this time, Abeona Therapeutics' Reconciled Depreciation is very stable compared to the past year.
Abeona Therapeutics income statement Correlations
Click cells to compare fundamentals
Abeona Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Abeona Therapeutics income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Depreciation And Amortization | 9.9M | 38.8M | 35.8M | 572K | 3.2M | 4.2M | |
Interest Expense | 400K | 4.1M | 3.7M | 736K | 418K | 397.1K | |
Selling General Administrative | 20.7M | 23.8M | 22.8M | 17.3M | 19.0M | 18.1M | |
Total Revenue | 0.0 | 10M | 3M | 1.4M | 3.5M | 3.3M | |
Gross Profit | (8.7M) | (20.1M) | (1.5M) | 964K | 302K | 286.9K | |
Other Operating Expenses | 77.1M | 58.5M | 60.4M | 46.7M | 51.7M | 54.3M | |
Operating Income | (77.1M) | (81.4M) | (89.8M) | (45.3M) | (48.2M) | (45.8M) | |
Ebit | (77.1M) | (81.4M) | (89.8M) | (45.3M) | (48.2M) | (45.8M) | |
Research Development | 48.6M | 30.1M | 34.3M | 29.0M | 31.1M | 32.6M | |
Ebitda | (67.2M) | (42.6M) | (54.1M) | (44.7M) | (45.0M) | (42.8M) | |
Total Operating Expenses | 77.1M | 58.5M | 60.4M | 46.2M | 48.5M | 50.9M | |
Income Before Tax | (76.3M) | (84.2M) | (84.9M) | (39.7M) | (54.2M) | (51.5M) | |
Net Income | (76.7M) | (88.3M) | (88.6M) | (31.8M) | (54.2M) | (51.5M) | |
Cost Of Revenue | 8.7M | 30.1M | 4.5M | 450K | 3.2M | 3.0M | |
Total Other Income Expense Net | 808K | (2.8M) | 4.9M | 5.6M | (6.0M) | (5.7M) | |
Income Tax Expense | 400K | 4.1M | 3.7M | (7.9M) | (9.1M) | (8.6M) | |
Net Income From Continuing Ops | (77.5M) | (84.2M) | (84.9M) | (39.7M) | (54.2M) | (56.9M) | |
Net Income Applicable To Common Shares | (76.3M) | (84.2M) | (84.9M) | (43.5M) | (39.1M) | (41.1M) | |
Interest Income | 1.2M | 1.3M | 69K | 431K | 2.1M | 1.2M | |
Net Interest Income | 808K | (2.8M) | (3.6M) | (305K) | 1.7M | 1.8M | |
Reconciled Depreciation | 7.8M | 4.6M | 3.3M | 4.6M | 3.2M | 4.2M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Abeona Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Abeona Therapeutics' short interest history, or implied volatility extrapolated from Abeona Therapeutics options trading.
Pair Trading with Abeona Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abeona Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abeona Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Abeona Stock
0.65 | MDGL | Madrigal Pharmaceuticals Financial Report 14th of May 2024 | PairCorr |
Moving against Abeona Stock
0.79 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
0.73 | ME | 23Andme Holding | PairCorr |
0.64 | MCRB | Seres Therapeutics Financial Report 14th of May 2024 | PairCorr |
0.64 | VALN | Valneva SE ADR Financial Report 2nd of May 2024 | PairCorr |
0.63 | MBIO | Mustang Bio Report 3rd of April 2024 | PairCorr |
The ability to find closely correlated positions to Abeona Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abeona Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abeona Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abeona Therapeutics to buy it.
The correlation of Abeona Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abeona Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abeona Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abeona Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abeona Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.Note that the Abeona Therapeutics information on this page should be used as a complementary analysis to other Abeona Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Abeona Stock analysis
When running Abeona Therapeutics' price analysis, check to measure Abeona Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abeona Therapeutics is operating at the current time. Most of Abeona Therapeutics' value examination focuses on studying past and present price action to predict the probability of Abeona Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abeona Therapeutics' price. Additionally, you may evaluate how the addition of Abeona Therapeutics to your portfolios can decrease your overall portfolio volatility.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Stocks Directory Find actively traded stocks across global markets | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Is Abeona Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abeona Therapeutics. If investors know Abeona will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abeona Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.53) | Revenue Per Share 0.164 | Quarterly Revenue Growth (1.00) | Return On Assets (0.47) | Return On Equity (2.61) |
The market value of Abeona Therapeutics is measured differently than its book value, which is the value of Abeona that is recorded on the company's balance sheet. Investors also form their own opinion of Abeona Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Abeona Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abeona Therapeutics' market value can be influenced by many factors that don't directly affect Abeona Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abeona Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abeona Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abeona Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.